Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03628287 · ClinicalTrials.gov registry record · NA
Program Refinements to Optimize Model Impact and Scalability Based on Evidence
A NA study, sponsored by City University of New York, School of Public Health.
- Completed
- Registry status
- NA
- Development phase
- 960
- Enrollment target
NCT03628287 is a NA study that has completed, run by City University of New York, School of Public Health. The registered enrollment target is 960 participants.
The verdict
NCT03628287, a NA study, has completed, sponsored by City University of New York, School of Public Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 960 participants
- Enrollment target
Study Summary
In New York, the achievement of 90-90-90 goals is jeopardized not by limited access to affordable care and treatment, but by persistent disparities in HIV viral suppression (VS). Complex behavioral and structural barriers to achieving and maintaining VS require coordinated, combination approaches to meet medical and social service needs. In 2009, at 28 Ryan White Part A (RWPA)-funded agencies, the New York City (NYC) Department of Health and Mental Hygiene (DOHMH) launched a multi-component HIV Care Coordination Program (CCP) directed toward the most vulnerable persons living with HIV (PLWH) in NYC. A systematic CCP effectiveness study began in 2013 (R01 MH101028; PIs: Irvine, Nash). Findings to date suggest that the CCP is superior to usual care for vulnerable subgroups of PLWH, but there remains substantial room for improvement in short- and long-term VS. In an immediate evidence-to-practice feedback loop, the DOHMH is implementing a refined CCP model in 2018. Greater focusing, tailoring and cues for delivery of key components are expected to increase CCP engagement, reach, fidelity, scalability, effectiveness and impact. The aim of the proposed study is to estimate the effect of the revised (vs. original) CCP on timely VS (within 4 months of enrollment), using experimental methods.
Interventions
- OTHER Revised Care Coordination Program
- OTHER Original Care Coordination Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 960 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2023-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03628287
The ClinicalTrials.gov registry entry for NCT03628287 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 960 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City University of New York, School of Public Health, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Revised Care Coordination Program is the first listed.
NCT03628287 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03628287 about?
NCT03628287 is a clinical study titled "Program Refinements to Optimize Model Impact and Scalability Based on Evidence". In New York, the achievement of 90-90-90 goals is jeopardized not by limited access to affordable care and treatment, but by persistent disparities in HIV viral suppression (VS). Complex behavioral and structural barriers to achieving and maintaining VS require coordinated, combination approaches to...
What is the current status of trial NCT03628287?
This trial is currently completed. It is a NA study. The enrollment target is 960 participants. The study started on 2018-08-01. Estimated completion is 2023-01-31.
What interventions are being tested in trial NCT03628287?
The interventions under investigation include: Revised Care Coordination Program (OTHER), Original Care Coordination Program (OTHER).
Who is sponsoring clinical trial NCT03628287?
This trial is sponsored by City University of New York, School of Public Health, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.